Kiran Mazumdar-Shaw is a prominent Indian billionaire entrepreneur and the executive chairperson of Biocon Limited, a global biopharmaceutical enterprise. Born on March 23, 1953, in Bengaluru, Karnataka, she has become a central figure in the Indian biotechnology sector, recognized for her role in pioneering the industry and advocating for affordable medical innovation. Mazumdar-Shaw’s educational background laid the groundwork for a career that challenged conventional professional norms. She attended Bishop Cotton Girl's High School in Bengaluru, graduating in 1968, and subsequently earned a bachelor’s degree in zoology from Mount Carmel College, an affiliate of Bangalore University, in 1973. Initially aspiring to attend medical school, she ultimately followed in her father’s footsteps in a different capacity. Her father, Rasendra Mazumdar, served as the head brewmaster at United Breweries, and at his suggestion, she pursued training in fermentation science. She attended the Ballarat College (now Federation University Australia) in Melbourne, where she was the only woman in her course, earning a degree as a master brewer in 1975. Despite her qualifications, Mazumdar-Shaw faced gender-based barriers when seeking employment in the brewing industry in India. This professional challenge, combined with a fortuitous meeting with Leslie Auchincloss, the founder of the Irish company Biocon Biochemicals, prompted a shift in her career trajectory. In 1978, she founded Biocon India in a garage in Bengaluru with a modest seed capital of ₹10,000. While initially a joint venture focused on producing industrial enzymes for the food, brewing, and textile industries, the company eventually evolved under her leadership. In the decades that followed, Mazumdar-Shaw steered Biocon from an enzyme manufacturer into a complex biopharmaceutical company. A critical turning point occurred in 1989 when Unilever acquired the interest held by her partner, Leslie Auchincloss. Through subsequent changes in equity ownership—including Imperial Chemical Industries buying Unilever's stake—Mazumdar-Shaw and her husband, John Shaw, eventually consolidated control. In 2004, acting on advice to expand, she took Biocon public. The company became the first biotechnology firm in India to issue an initial public offering (IPO), which was significantly oversubscribed. Her business philosophy has long been anchored in "affordable innovation," focusing on making therapeutics—particularly for chronic conditions like diabetes and cancer—accessible to patients in developing and developed nations. Her efforts to establish Biocon’s research and development capabilities earned her international recognition, including the Othmer Gold Medal (2014) for her contributions to science and chemistry. Mazumdar-Shaw’s contributions have been recognized with numerous honors, including the Padma Shri (1989) and the Padma Bhushan (2005) from the Government of India. In 2020, she received the Order of Australia, the country’s highest civilian honor, for her work in strengthening bilateral ties. She was also named the EY World Entrepreneur of the Year in 2020. In her personal life, she was married to Scotsman John Shaw, a former executive at Madura Coats who played a vital role in Biocon’s financial and strategic development. John Shaw joined the company in 1999, served as its vice chairman, and remained a central partner until his passing in October 2022. Outside of her corporate responsibilities, Mazumdar-Shaw has been deeply involved in philanthropy through the Biocon Foundation, which supports initiatives in healthcare, education, and infrastructure, particularly in rural Karnataka. She has also served on the boards of various academic and professional institutions, including the Indian Institute of Management Bangalore.